These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer. Lee SY; Jung DK; Choi JE; Jin CC; Hong MJ; Do SK; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Park JY Gene; 2017 Jan; 599():28-35. PubMed ID: 27838455 [TBL] [Abstract][Full Text] [Related]
10. DNA methylation in lung cancer. Park IK N Engl J Med; 2008 Jun; 358(23):2513; author reply 2514. PubMed ID: 18536092 [No Abstract] [Full Text] [Related]
11. A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors. Kratz JR; Van den Eeden SK; He J; Jablons DM; Mann MJ JAMA; 2012 Oct; 308(16):1629-31. PubMed ID: 23093159 [No Abstract] [Full Text] [Related]
12. Prognostic value of CD4+ lymphocytes in pleural cavity of patients with non-small cell lung cancer. Takahashi K; Saito S; Kamamura Y; Katakawa M; Monden Y Thorax; 2001 Aug; 56(8):639-42. PubMed ID: 11462067 [TBL] [Abstract][Full Text] [Related]
13. Refining prognosis in non-small-cell lung cancer. Sun Z; Yang P N Engl J Med; 2007 Jan; 356(2):189-90; author reply 190-1. PubMed ID: 17215540 [No Abstract] [Full Text] [Related]
14. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
15. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer. Komaki R; Milas L; Ro JY; Fujii T; Perkins P; Allen P; Sikes CR; Mountain CF; Ordonez NG Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):787-96. PubMed ID: 9531362 [TBL] [Abstract][Full Text] [Related]
16. Five-gene signature in non-small-cell lung cancer. Gounaris I N Engl J Med; 2007 Apr; 356(15):1582; author reply 1583. PubMed ID: 17436431 [No Abstract] [Full Text] [Related]
17. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583 [TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789 [TBL] [Abstract][Full Text] [Related]
19. Five-gene signature in non-small-cell lung cancer. Raz DJ; Jablons DM N Engl J Med; 2007 Apr; 356(15):1582; author reply 1583. PubMed ID: 17436432 [No Abstract] [Full Text] [Related]
20. Antigens, receptors and dominant oncogenes and the prognosis of non-small cell lung cancer. Stahel RA Lung Cancer; 1994 Nov; 11 Suppl 3():S31-8. PubMed ID: 7704510 [No Abstract] [Full Text] [Related] [Next] [New Search]